Clinical Minute: Retina: Features Associated with Progression to GA in AMD

Show Description +

WHO: Maria Berrocal, MD, and Usha Chakravarthy, MD, PhD WHAT: A discussion on retinal features predicting geographic atrophy risk in AMD, emphasizing advanced imaging techniques and AI applications. WHEN: Study published September 2021 WHERE: Ophthalmology Retina WHY: To improve the understanding of signs predicting GA in AMD patients. KEY DISCUSSION: Dr. Chakravarthy discusses retinal features, such as the loss of RPE and EZ, that mark GA progression, using advanced imaging to refine clinical assessments. (skip to 3:20 for this conversation)

Posted: 11/04/2024

Up Next

Clinical Minute: Retina: Simultaneous UWF Imaging with OCT and FFA/ICGA

Paulo E. Stanga, MD, and Maria H. Berrocal, MD


Clinical Minute: Retina: AI in ROP

María Berrocal, MD and Darius Moshfeghi, MD

Clinical Minute: Retina: The Mac Tel Project

María Berrocal, MD and Lihteh Wu, MD

Clinical Minute: Retina: The Future of the PDS with Ranibizumab

Dante Pieramici, MD and María Berrocal, MD

Clinical Minute Retina: PPV for VH Secondary to RVO

Ramin Tadayoni, MD, PhD and Carl Regillo, MD

GATHER2 Data at 1 and 2 Years

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

Biosimilars in Retina

Ramin Tadayoni, MD, PhD, and Prof. Frank Holz

Meta-analysis of Anti-VEGF Agents in Wet AMD Therapy

Ramin Tadayoni, MD, PhD and Jean-Francois Korobelnik, MD, PhD

PPV vs Conventional Therapy for PDR

María H. Berrocal, MD, and Ramin Tadayoni, MD, PhD

GA Therapy After the Newest DERBY/OAKS Data

Eleonora Lad, MD, PhD and Ramin Tadayoni, MD, PhD

Protocol AC: Step Therapy in DME

Chirag D. Jhaveri, MD; and Prof. Ramin Tadayoni

TRUCKEE Study Data

Ramin Tadayoni, MD, PhD and Arshad Khanani, MD, MA

Pegcetacoplan Phase 3 Data

Ramin Tadayoni, MD, PhD and Caroline Baumal, MD

Rates of Endophthalmitis in a Nationwide Study

Ramin Tadayoni, MD, PhD; and Catherine Creuzot-Garcher, MD

Why Some Clinical Trials Succeed Where Others Do Not

Ramin Tadayoni, MD, PhD; and Peter Kaiser, MD

AI in Retinal Imaging

Ramin Tadayoni, MD, PhD; Ursula Schmidt-Erfurth, MD

Intraoperative OCT: From Concept to Execution

Ramin Tadayoni, MD, PhD; and Cynthia Toth, MD

AI in the Modern Age of Retina

Anat Loewenstein MD, MHA

The History of ILM Staining

Ramin Tadayoni MD, PhD; and Kazuaki Kadonosono, MD, PhD

Phase 3 Faricimab Data and the Dawn of a New Molecule

Ramin Tadayoni, MD, PhD and Charles Wykoff, MD, PhD

Growing Comfortable with the Suprachoroidal Space

Maria Berrocal, MD, and Robert L. Avery, MD

Update on Predatory "Cell Therapy" Clinics

María H. Berrocal, MD and Ajay Kuriyan, MD

Is Teleretinal Screening for DR and DME Effective?

María H. Berrocal, MD; and Christina Y. Weng, MD, MBA

Clinical Minute: Retina: Features Associated with Progression to GA in AMD

WHO: Maria Berrocal, MD, and Usha Chakravarthy, MD, PhD WHAT: A discussion on retinal features predicting geographic atrophy risk in AMD, emphasizing advanced imaging techniques and AI applications. WHEN: Study published September 2021 WHERE: Ophthalmology Retina WHY: To improve the understanding of signs predicting GA in AMD patients. KEY DISCUSSION: Dr. Chakravarthy discusses retinal features, such as the loss of RPE and EZ, that mark GA progression, using advanced imaging to refine clinical assessments. (skip to 3:20 for this conversation)

Posted: 11/04/2024


Please log in to leave a comment.